

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Ursolic acid, a naturally occurring triterpenoid, induces the apoptosis of human cancer cells through multiple signaling pathways. A 50 µmol/l dose of ursonic acid decreased the mRNA expression levels of anti-apoptotic NF-κBp65 and Bcl-2 0.17 (8.9/52.6)-fold and 0.22 (9.5/42.3)‑fold, respectively. The proliferative activity of T24 cells treated with 12.5, 25.0 and 50.0 µmol/l ursolic acid was significantly reduced compared with that of control cells (83.8, 56.2 and 31.5 vs. 97.6%, respectively, P<0.05 for each). Ursolic acid is important in inducing apoptosis via the suppression of Akt/NF-κB signaling in T24 human bladder cancer cells and this occurs in a dose-dependent manner[3]. Treatment of B16F-10 cells with nontoxic concentration of ursolic acid showed the presence of apoptotic bodies and induced DNA fragmentation in a dose depended manner. The pro-inflammatory cytokine production and gene expression of TNF-alpha, IL-1beta, IL-6 and GM-CSF were down regulated in ursolic acid treated cells compared to nontreated B16F-10 metastatic melanoma cells[4]. UA (Ursonic Acid) inhibited constitutive and TNF-α-induced activation of NF-κB in DU145 and LNCaP cells in a dose-dependent manner. Furthermore, UA suppressed both constitutive and inducible STAT3 activation in prostate cancer cells concomitant with suppression of activation of upstream kinases (Src and JAK2) and STAT3-dependent reporter gene activity. In vivo, UA (200 mg/kg b.w.) treated for 6 weeks inhibited the growth of DU145 cells in nude mice without any significant effect on body weight[5]. |
| Concentration | Treated Time | Description | References | |
| Vero cells | 2.5, 5, 10 µM | 16 hours | To evaluate the antiviral effect of UNA on PEDV. The results showed that UNA significantly inhibited PEDV replication. | Vet Res. 2024 May 23;55(1):67 |
| ST cells | 2.5, 5, 10 µM | 18 hours | To evaluate the antiviral effect of UNA on SVA. The results showed that UNA significantly inhibited SVA replication. | Vet Res. 2024 May 23;55(1):67 |
| Porcine alveolar macrophages (PAMs) | 2.5, 5, 10 µM | 24 hours | To verify the antiviral activity of UNA in porcine cells. The results showed that UNA significantly decreased the PRRSV ORF7 mRNA level, N protein expression, and viral titre in a concentration-dependent manner. | Vet Res. 2024 May 23;55(1):67 |
| Marc-145 cells | 2.5, 5, 10 µM | 48 hours | To evaluate the inhibitory effect of UNA on PRRSV replication. The results showed that UNA inhibited PRRSV genome replication, viral protein expression and virus production in a dose-dependent manner. | Vet Res. 2024 May 23;55(1):67 |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6 mice | Experimental autoimmune encephalomyelitis (EAE) model | Oral | 50 mg/kg | Once daily for 10 days | To evaluate the therapeutic effects of ursonic acid on multiple sclerosis, showing significant improvement in clinical symptoms and pathological features of the EAE model. | Chem Sci. 2021 Dec 21;13(4):1060-1079 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.20mL 0.44mL 0.22mL |
11.00mL 2.20mL 1.10mL |
21.99mL 4.40mL 2.20mL |
|
| CAS号 | 6246-46-4 |
| 分子式 | C30H46O3 |
| 分子量 | 454.68 |
| SMILES Code | O=C([C@]1(CC[C@@]2(C)[C@]3(C)CC[C@@]4([H])C5(C)C)CC[C@@H](C)[C@H](C)[C@@]1([H])C2=CC[C@]3([H])[C@@]4(C)CCC5=O)O |
| MDL No. | MFCD09752413 |
| 别名 | 3-Ketoursolic acid; Prunol; 3-beta-hydroxyurs-12-en-28-oic acid; TOS-BB-0966; CCRIS 7123; NSC4060; beta-Ursolic acid; Malol |
| 运输 | 蓝冰 |
| InChI Key | MUCRYNWJQNHDJH-OADIDDRXSA-N |
| Pubchem ID | 9890209 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 50 mg/mL(109.97 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1